QL
KYMR icon

Quarry LP’s Kymera Therapeutics KYMR Stock Holding History

Quarry LP’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03K Buy
+9
New +$773 ﹤0.01% 1955
2024
Q4 		– Sell
-2,000
Closed -$94.7K – 1837
2024
Q3 		$94.7K Buy
+2,000
New +$88.3K 0.02% 448

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Quarry LP's KYMR Position: Q2 2026 in Review

Quarry LP opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 9 shares worth $1.03K. The stake represents ﹤0.01% of the portfolio and ranks #1955 among its holdings. This is a return to the name: Quarry LP previously reported a position in KYMR as recently as Q3 2024.

Quarry LP first reported a position in KYMR in Q3 2024 and has held it in 2 quarters since. The position peaked at $94.7K in Q3 2024. 277 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Quarry LP held 9 shares of Kymera Therapeutics worth $1.03K as of Q2 2026.
  • Kymera Therapeutics was a new Quarry LP position in Q2 2026.
  • Kymera Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1955 holding.
  • Quarry LP first reported a position in Kymera Therapeutics in Q3 2024 and has held it in 2 quarters since.
  • Quarry LP's Kymera Therapeutics position peaked at $94.7K in Q3 2024.
  • 277 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.